Validation of a Toll-like Receptor (TLR)2/TLR1 Activation Assay for Biological Standardization of Arthrospira/Limnospira Immune-Enhancing Potency
Mona H. Haron,Jin Zhang,Amar G. Chittiboyina,Ikhlas A. Khan,Nirmal D. Pugh,Mona H. HaronJin ZhangAmar G. ChittiboyinaIkhlas A. KhanNirmal D. Pugha National Center for Natural Products Research,Research Institute of Pharmaceutical Sciences,School of Pharmacy,The University of Mississippi,University,MS,USAb Department of BioMolecular Sciences,School of Pharmacy,The University of Mississippi,University,MS,USAMona H. Haron,PhD,is a Research Scientist,National Center for Natural Products Research,School of Pharmacy,University of Mississippi. Research focus includes pharmacological properties of medicinal plants and their phytochemical constituents,particularly immune-enhancing and neuro-active agents. A special interest in studying the pharmacokinetic herb-drug interactions and safety of herbal supplements.Jin Zhang,PhD,is a Research Scientist at the National Center for Natural Products Research,School of Pharmacy,University of Mississippi,with extensive research experience in natural products/biological chemistry. Jin Zhang's interests include immune-enhancing,anticancer,cell signaling,high throughput screening,isolation and structure elucidation of biologically active compounds in natural products.Amar G. Chittiboyina,PhD,Assistant Director,National Center for Natural Products Research,Research Institute of Pharmaceutical Sciences,School of Pharmacy,University of Mississippi. Broad background in organic chemistry,with specific training and expertise in organic and medicinal chemistry,natural products,and analytical chemistry. Holder of several national,international patents,has authored over 120 peer-reviewed research articles in various scientific journals. His research interests include biogenesis of secondary metabolites; development of synthetic methods for commercial viability; safer and greener ways to produce natural products in gram quantities; synthesis and structure-activity relationships (SAR); implementation of orthogonal methods for the quality assessment of phytochemicals in various matrices; development of non-animal alternative methods in dermatotoxicology; application of computational tools to address the adverse effects such as potential herb-herb and herb-drug interactions associated with phytochemicals. Dr. Chittiboyina received his Ph.D. degree from the National Chemical Laboratory,Pune,India,followed by postdoctoral training at the Department of Medicinal Chemistry,University of Mississippi. Dr. Chittiboyina serves as a consultant for several small biotech companies and well versed in grantsmanship and technology transfer aspects.Ikhlas A. Khan,PhD,is Director and Research Professor of Pharmacognosy at the National Center for Natural Products Research. Main areas of research include phytomedicine,drug discovery,medicinal plants research,analytical fingerprinting for standardization of herbal products,bio-analytical approaches to improvement of product quality and safety,development of analytical methods for phytochemical characterization of biologically active natural products.Nirmal D. Pugh,PhD,is a Principal Scientist at the National Center for Natural Products Research with a background in pharmacognosy and performs research on botanicals.
DOI: https://doi.org/10.1080/19390211.2023.2263566
2023-10-06
Journal of Dietary Supplements
Abstract:Arthrospira/Limnospira is a popular botanical dietary supplement throughout the world and has been consumed as a food product for hundreds of years. Ongoing efforts from our research group are focused on evaluating the utility of a Limnospira -derived oral supplement (Immulina) in promoting resilience against influenza viral infection. Like other botanical extracts, Immulina is inherently a complex matrix with variation in the levels of its chemical constituents. Therefore, to ensure therapeutic consistency for future scientific research and clinical studies, we are developing standardization technology using a bioassay and chemical markers. Braun-type lipoproteins, a class of macromolecules that activate the Toll-like receptor (TLR)2/TLR1 signaling pathway, have been identified as a major active component within Immulina. Based on the mechanism of action of the Braun-type lipoproteins, an in vitro bioassay was established using the HEK-Blue hTLR2/TLR1 cell line to quantitate the immune-enhancing potency of Immulina. The objective of the current research was to validate that bioassay for Immulina activity quantification using the U.S. FDA guidance document for botanical drug development and U.S. Pharmacopeia recommendations. System suitability, reference standards and defining potency units were established. Validation of performance parameters included precision, specificity, accuracy, linearity, and range. Validating this bioassay for Immulina activity provides a tool for ensuring product consistency and quantifying the potency of this botanical for use in future research as well as material in the consumer market.